Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): Pooled subset analyses from two randomized trials
- Ramalingam, S.S.
- O'Byrne, K.
- Boyer, M.
- Mok, T.
- Jänne, P.A.
- Zhang, H.
- Liang, J.
- Taylor, I.
- Sbar, E.I.
- Paz-Ares, L.
ISSN: 1569-8041, 0923-7534
Année de publication: 2016
Volumen: 27
Número: 3
Pages: 423-429
Type: Article